The growing popularity of Ozempic and other GLP-1s in recent years is garnering greater attention from oncologists interested in how these drugs could affect cancer care and cancer rates.

A recent survey found 62% of pulmonologists said they order biomarker testing for non-small cell lung cancer patients. Among those who said they do not order such testing, 84% said the reason is they believe it is the oncologist's responsibility, according to a study published June 19 in CHEST Journal.

The highest numbers of breast and cervical cancer deaths are found mostly in southeastern states, according to new data from the "2024 State Scorecard on Women’s Health and Reproductive Care" released July 18 by The Commonwealth Fund.

The drug cyclophosphamide prevented bone marrow transplant complications for patients with "mismatched" donors, according to a study published July 17 in the Journal of Clinical Oncology.

Existing screening protocols in place are failing to identify patients who might be carriers of a genetic mutation that is linked to certain cancers, according to Mayo Clinic researchers. 

An EHR reminder, or "nudge," can reduce unnecessary breast cancer surgeries, according to a study published July 17 in JAMA Surgery.

Eugene Kim, MD, has been named surgeon-in-chief and associate director of surgery at Torrance, Calif.-based Cedars-Sinai Guerin Children's.

A University of California Irvine study reported 90% patient satisfaction in cancer patients who were offered a multilanguage electronic tool to report their symptoms.

A clinical trial conducted by researchers at Rochester, Minn.-based Mayo Clinic and Minneapolis-based University of Minnesota found drug combinations eliminated or shrunk tumors in 70% of clinical trial participants with stage 3 melanoma. 

The FDA has given fast-track designation to Diakonos Oncology for its pancreatic cancer vaccine.

Tampa (Fla.) General Hospital has received a "substantial" gift to develop a center of colorectal cancer excellence. 

The median compensation for hematologists and medical oncologists increased 7.1% from 2023 to 2024, going from $498,062 to $533,402, according to the American Medical Group Association.

A University of Cambridge poll found 70% of people fear a late cancer diagnosis.

Cancer Resource Center of the Finger Lakes has affiliated with Ithaca, N.Y.-based Cayuga Health System, effective July 1. 

Carilion Clinic in Roanoke, Va., received a $25 million gift to grow the health system's cancer program.

Among adults 30 and older, about 40% of cancer cases and nearly a half of all cancer deaths are linked to preventable risk factors, according to a new study from researchers at the American Cancer Society. 

Findings from a recent study challenge a push to reclassify low grade prostate cancer, Biopsy Gleason Grade Group 1, as "benign." 

A Boston-based Harvard Medical School study found oncologists unsure how to handle artificial intelligence if it presents a treatment plan they would not recommend.

CAR-T therapy is becoming a more frequent treatment for Medicare patients with diffuse large B-cell lymphoma, but changes in CAR-T treatments that push it as an earlier line of therapy may change where patients receive the therapy — and ultimately, its cost.

The blood pressure drug Losartan may be able to block a gene found in the blood, angiotensin II receptor type 1 (AGTR1), and improve the effectiveness of chemotherapy, according to a study published June 19 in Science Translational Medicine.